Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010-2013 Article

Feldman, David I, Valero-Elizondo, Javier, Salami, Joseph A et al. (2018). Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010-2013 . 7(3), 64-67. 10.1097/XCE.0000000000000151

cited authors

  • Feldman, David I; Valero-Elizondo, Javier; Salami, Joseph A; Rana, Jamal S; Ogunmoroti, Oluseye; Okunrintemi, Victor; Osondu, Chukwuemeka U; Spatz, Erica S; Virani, Salim S; Blankstein, Ron; Blaha, Michael J; Veledar, Emir; Nasir, Khurram

authors

publication date

  • September 1, 2018

keywords

  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Life Sciences & Biomedicine
  • Science & Technology
  • atherosclerotic cardiovascular disease
  • cardiovascular prevention
  • cost-effectiveness
  • diabetes mellitus

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 64

end page

  • 67

volume

  • 7

issue

  • 3